Literature DB >> 28187023

Validation and Calibration of the Risk Stratification Index.

George F Chamoun1, Linyan Li, Nassib G Chamoun, Vikas Saini, Daniel I Sessler.   

Abstract

BACKGROUND: The Risk Stratification Index was developed from 35 million Medicare hospitalizations from 2001 to 2006 but has yet to be externally validated on an independent large national data set, nor has it been calibrated. Finally, the Medicare Analysis and Provider Review file now allows 25 rather than 9 diagnostic codes and 25 rather than 6 procedure codes and includes present-on-admission flags. The authors sought to validate the index on new data, test the impact of present-on-admission codes, test the impact of the expansion to 25 diagnostic and procedure codes, and calibrate the model.
METHODS: The authors applied the original index coefficients to 39,753,036 records from the 2007-2012 Medicare Analysis data set and calibrated the model. The authors compared their results with 25 diagnostic and 25 procedure codes, with results after restricting the model to the first 9 diagnostic and 6 procedure codes and to codes present on admission.
RESULTS: The original coefficients applied to the 2007-2012 data set yielded C statistics of 0.83 for 1-yr mortality, 0.84 for 30-day mortality, 0.94 for in-hospital mortality, and 0.86 for median length of stay-values nearly identical to those originally reported. Calibration equations performed well against observed outcomes. The 2007-2012 model discriminated similarly when codes were restricted to nine diagnostic and six procedure codes. Present-on-admission models were about 10% less predictive for in-hospital mortality and hospital length of stay but were comparably predictive for 30-day and 1-yr mortality.
CONCLUSIONS: Risk stratification performance was largely unchanged by additional diagnostic and procedure codes and only slightly worsened by restricting analysis to codes present on admission. The Risk Stratification Index, after calibration, thus provides excellent discrimination and calibration for important health services outcomes and thus appears to be a good basis for making hospital comparisons.

Entities:  

Mesh:

Year:  2017        PMID: 28187023     DOI: 10.1097/ALN.0000000000001560

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  3 in total

1.  Association Between First-Line Immune Checkpoint Inhibition and Survival for Medicare-Insured Patients With Advanced Non-Small Cell Lung Cancer.

Authors:  Kenneth L Kehl; Scott Greenwald; Nassib G Chamoun; Paul J Manberg; Deborah Schrag
Journal:  JAMA Netw Open       Date:  2021-05-03

2.  Application of the Risk Stratification Index to Multilevel Models of All-condition 30-Day Mortality in Hospitalized Populations Over the Age of 65.

Authors:  Vikas Saini; Valérie Gopinath
Journal:  Med Care       Date:  2021-09-01       Impact factor: 3.178

3.  Covid-19 and excess mortality in medicare beneficiaries.

Authors:  Scott D Greenwald; Nassib G Chamoun; Paul J Manberg; Josh Gray; David Clain; Kamal Maheshwari; Daniel I Sessler
Journal:  PLoS One       Date:  2022-02-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.